Teladoc Health (NYSE:TDOC - Get Free Report) is anticipated to announce its Q2 2025 earnings results after the market closes on Tuesday, July 29th. Analysts expect the company to announce earnings of ($0.24) per share and revenue of $621.91 million for the quarter.
Teladoc Health Stock Up 1.3%
Shares of TDOC traded up $0.11 during midday trading on Tuesday, hitting $8.44. The stock had a trading volume of 7,269,605 shares, compared to its average volume of 6,397,407. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.68 and a quick ratio of 1.64. The firm has a market cap of $1.48 billion, a price-to-earnings ratio of -1.43 and a beta of 1.84. The company has a 50 day simple moving average of $7.57 and a two-hundred day simple moving average of $8.62. Teladoc Health has a twelve month low of $6.35 and a twelve month high of $15.21.
Insider Activity
In other Teladoc Health news, insider Carlos Nueno sold 3,958 shares of the stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total transaction of $27,151.88. Following the transaction, the insider owned 17,645 shares in the company, valued at approximately $121,044.70. This represents a 18.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Adam C. Vandervoort sold 5,808 shares of Teladoc Health stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total transaction of $39,842.88. Following the sale, the insider directly owned 69,773 shares in the company, valued at approximately $478,642.78. This trade represents a 7.68% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 18,656 shares of company stock worth $128,189. 0.58% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Teladoc Health
Several large investors have recently bought and sold shares of TDOC. NewEdge Advisors LLC raised its stake in shares of Teladoc Health by 1,278.7% during the 1st quarter. NewEdge Advisors LLC now owns 11,305 shares of the health services provider's stock worth $90,000 after buying an additional 10,485 shares in the last quarter. Acadian Asset Management LLC purchased a new stake in shares of Teladoc Health during the 1st quarter worth $615,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Teladoc Health by 2.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 193,714 shares of the health services provider's stock worth $1,542,000 after acquiring an additional 5,235 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Teladoc Health by 5.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 447,992 shares of the health services provider's stock valued at $3,566,000 after purchasing an additional 24,124 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company's stock.
Wall Street Analyst Weigh In
TDOC has been the topic of a number of recent analyst reports. Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a research report on Thursday, May 1st. Citigroup dropped their price target on shares of Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a research note on Friday, April 25th. The Goldman Sachs Group decreased their price target on Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Evercore ISI upped their price target on Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a research note on Wednesday, July 9th. Finally, Bank of America decreased their price objective on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a report on Wednesday, May 28th. Twelve research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $9.65.
Get Our Latest Report on TDOC
About Teladoc Health
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Stories
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
